At Ananta Technologies, our mission is to revolutionize cell therapy manufacturing with innovative bioreactor solutions. We are developing the CentriFLEX bioreactor that balances centrifugal and fluid forces to grow cells, enabling continuous cell culture refreshment without the use of membrane filters. Our proof-of-concept research has shown that the CentriFLEX meets competitive performance metrics, achieving viable cell densities over 100 million cells/mL, maintaining cell growth at 95% of the maximum rate, and reducing manufacturing time by 30%. With its scalable design, the CentriFLEX addresses existing cell manufacturing limitations, potentially lowering the financial barrier to life-saving cell therapies.